Ghent University Academic Bibliography

Your filters: cql: parent exact "FRONTIERS IN PHARMACOLOGY"

Add to list
- Journal Article
- A1
- open access
Comparative evaluation of Oxford Nanopore Technologies' adaptive sampling and the Twist long-read PGx panel for pharmacogenomic profiling

Koen Deserranno (UGent) , Laurentijn Tilleman (UGent) , Dieter Deforce (UGent) and Filip Van Nieuwerburgh (UGent)

(2025) FRONTIERS IN PHARMACOLOGY. 16.
Add to list
- Journal Article
- A1
- open access
Patients’ knowledge, preferences, and perspectives about data protection and data control : an exploratory survey

Teodora Lalova-Spinks (UGent) , Robbe Saesen, Mitchell Silva, Jan Geissler, Iryna Shakhnenko, Jennifer Catherine Camaradou and Isabelle Huys

(2024) FRONTIERS IN PHARMACOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity : a Swedish national register-based cohort study

Cheïma Amrouch (UGent) , Davide Liborio Vetrano, Cecilia Damiano, Lu Dai, Amaia Calderón-Larrañaga, Maxim Grymonprez (UGent) , Marco Proietti, Gregory Lip, Søren Johnsen, Jonas Wastesson, et al.

(2024) FRONTIERS IN PHARMACOLOGY. 15.
Add to list
- Journal Article
- A1
- open access
Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling

Koen Deserranno (UGent) , Laurentijn Tilleman (UGent) , Kaat Rubben, Dieter Deforce (UGent) and Filip Van Nieuwerburgh (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
Parasitic infections related to anti-type 2 immunity monoclonal antibodies : a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)

Victor Pera, Guy Brusselle (UGent) , Sebastian Riemann (UGent) , Jan A. Kors, Erik M. Van Mulligen, Rowan Parry, Marcel de Wilde, Peter R. Rijnbeek and Katia Verhamme (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs

Nayra Cristina Herreira do Valle (UGent) , Simone Janssen (UGent) , Marcus C. M. Stroet, Sofie Pollenus, Sonja Van den Block, Nick Devoogdt, Jens Debacker (UGent) , Sophie Hernot and Hilde De Rooster (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
Berberine-microbiota interplay : orchestrating gut health through modulation of the gut microbiota and metabolic transformation into bioactive metabolites

Tessa Dehau, Marc Cherlet (UGent) , Siska Croubels (UGent) , Michiel Van de Vliet (UGent) , Evy Goossens (UGent) and Filip Van Immerseel (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
Bacterial responses to plant antimicrobials : the case of alkannin and shikonin derivatives

Angélique Rat (UGent) , Antigoni E. Koletti, Nebojsa Rodic, Vassilios P. Papageorgiou, Anne Willems (UGent) and Andreana N. Assimopoulou

(2023) FRONTIERS IN PHARMACOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study

Maxim Grymonprez (UGent) , Tine De Backer (UGent) , Xander Bertels (UGent) , Stephane Steurbaut and Lies Lahousse (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
The Abcc6a knockout zebrafish model as a novel tool for drug screening for pseudoxanthoma elasticum

Matthias Van Gils (UGent) , Andy Willaert (UGent) , Paul Coucke (UGent) and Olivier Vanakker (UGent)

(2022) FRONTIERS IN PHARMACOLOGY. 13.

Academic Bibliography

Comparative evaluation of Oxford Nanopore Technologies' adaptive sampling and the Twist long-read PGx panel for pharmacogenomic profiling

Patients’ knowledge, preferences, and perspectives about data protection and data control : an exploratory survey

Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity : a Swedish national register-based cohort study

Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling

Parasitic infections related to anti-type 2 immunity monoclonal antibodies : a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)

Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs

Berberine-microbiota interplay : orchestrating gut health through modulation of the gut microbiota and metabolic transformation into bioactive metabolites

Bacterial responses to plant antimicrobials : the case of alkannin and shikonin derivatives

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study

The Abcc6a knockout zebrafish model as a novel tool for drug screening for pseudoxanthoma elasticum

Contents

Support

Contact